Therapeutic Apheresis Market Size, Share & Outlook 2033

Q: What is the Therapeutic Apheresis Market CAGR for 2033?

The Therapeutic Apheresis Market CAGR for 2033 is 5.2%. Read Report

Therapeutic Apheresis Market Outlook

The demand for therapeutic apheresis is estimated to rise at a CAGR of 6.8% during the forecast period. The global therapeutic apheresis market share is projected to be valued at US$ 2,717.9 million in 2023 and is expected to reach US$ 5,264.4 million by 2033.

The demand for therapeutic apheresis is surging owing to growing incidences of chronic diseases and an increasing number of trauma and injury cases.

Apheresis is a procedure wherein blood is withdrawn from a donor’s body, extraction of one or more blood components such as platelets, plasma, and white blood cells, and transfusing of the remaining blood back into the donor during the procedure or at the end of it. Therapeutic apheresis is a process of removing blood components from a patient with apheresis technology.

Therapeutic apheresis is used for removing defective cells. It is also used for the treatment of conditions in which a component or a pathogenic substance in the blood causes morbidity.

Basically, there are three types of therapeutic apheresis procedures used, namely therapeutic plasma exchange (TPE), red blood cell exchange (RBCX), and cellular depletion. Therapeutic plasma exchange is the elimination of a huge volume of plasma from the patient and replacing the plasma with suitable fluids. TPE is commonly used for the treatment of autoimmune diseases or immune-mediated diseases or disorders.

TPE removes paraproteins, monoclonal antibiotics, antigen-antibody, and autoimmune antibody complexes. Therapeutic apheresis particularly removes the significant proportion of one or more components causing diseases.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

What Is Driving The Global Therapeutic Apheresis Sector?

Growing need for several blood components, increasing prevalence of accidents globally, and additional government initiatives toward blood donation are a few primary drivers accelerating the therapeutic apheresis industry.
The growing dominance of various therapeutic procedures such as fluid replacement therapy, red cell exchange, dendritic cells cancer therapy, car T cells therapy, and extracorporeal therapy is broadly stirring the growth rate of the global market.
Escalating trauma and injury cases, growing cases of chronic diseases, rising need for blood components and more awareness pertaining to blood safety, favorable reimbursement policies, and a growing number of complicated surgical procedures are all responsible for the lucrative growth of the market.
Constantly increasing geriatric population coupled with increasing healthcare expenditure and growing use of therapeutic apheresis in treating cancer is likely to boost the growth of the global therapeutic apheresis sector.

Attributes	Value
Therapeutic Apheresis Market Size (2023)	US$ 2,717.9 million
Therapeutic Apheresis Market Projected Size (2033)	US$ 5,264.4 million
Therapeutic Apheresis Market CAGR (2023 to 2033)	6.8%

Restraining Factors Hampering The Market Growth

Therapeutic apheresis procedures, apheresis devices, and installing the apheresis devices are an expensive affair and therefore the high cost associated with these procedures is anticipated to obstruct the growth of the therapeutic apheresis business.
Lack of awareness coupled with a dearth of qualified specialists and problems associated with apheresis methods is likely to suppress the global market expansion.
Apheresis results in the growing occurrence of several disorders and diseases such as the growth of germ cell tumors from stem cells of the germ line and early embryo, Guillain-Barré syndrome, Paraproteinemia, Waldenstrom's macroglobulinemia, non-Hodgkin’s lymphoma, symptomatic myeloma, and many others are broadly hindering the growth of the market.

Rental model’s installation of apheresis devices, strict donor recruitment criteria, and decreased blood donations using apheresis as a result of lack of awareness are likely to restrict the market further over the forecast period.

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Regional Analysis

Countries	Market Share (2022)
United States	28.8%
Germany	6.3%
Japan	4.2%

North America To Dominate The Therapeutic Apheresis Industry

North America accounted for the leading share, i.e. 32.6% market share in 2022. Factors like growing demand for plasma-derived medicines production and well-established healthcare infrastructure. This region has smooth accessibility to advanced blood collection technologies. It also has the presence of some of the significant apheresis companies in the region.

Additionally, reasons such as soaring initiatives by the government towards blood donation coupled with the rising need for blood components across the globe. Moreover, approval of the latest indications for apheresis treatment, such as acute disseminated encephalomyelitis, autoimmune haemolytic anemia, and neonatal cardiac lupus, support the growth of the market in this region.

Europe Likely To Portray A Promising Market For Therapeutic Apheresis

In 2022, Europe accounted for 29.8% market share in the global market, owing to the growing prevalence of blood disorders such as profuse bleeding and a decrease in platelet count.

This region witnessed increasing cases of chronic diseases such as autoimmune diseases and cancer, and a growing number of organ donors also is supporting the growth of the market in this region.

The escalation in the rate of occurrence of chronic diseases, growing necessity for plasma sources, additional activities considering blood safety, and an increasing number of complicated surgical procedures are also fuelling the Europe therapeutic apheresis sector.

Start-up Ecosystem In The Therapeutic Apheresis Industry

In June 2022, BioCaptiva raised nearly US$ 2.6 million in the latest seed funding to additionally develop its BioCaptis instrument which is an apheresis-based cell-free DNA capture device for using liquid biopsy testing. The financial round was led by existing investor Archangels, who joined Scottish Enterprise, Cancer Research Horizons, and novel investor Old College Capital.

Key Players Benchmarking The Therapeutic Apheresis Industry

The market has an oligopolistic structure and is characterized by frequent mergers and acquisitions. Industry companies frequently employ new product development and strategic partnerships as sustainability strategies.

Terumo BCT (US) and UniCAR-Therapy Bio-Medicine Technologies Co. cooperated in October 2019. (China). By establishing a new Shanghai Center of Excellence, this alliance aims to advance CAR T-cell therapy. This advancement also enabled Terumo to expand the scope of its apheresis and leukapheresis applications.
Fresenius Kabi invested EUR 30 million in the Dominican Republic to construct an apheresis and transfusion disposables facility in January 2020.

Key Players

Asahi Kasei Medical Co.
Haemonetics Corporation
Miltenyi Biotec
Cerus Corporation
Terumo BCT Inc.
Fresenius Kabi USA
Terumo Bct
B. Braun Melsungen AG
Nikkiso Co. Ltd.
Medica S.p.A.
Baxter Healthcare Corporation
Kawasumi Laboratories Inc.
Therakos Incorporation

Key Segments

By Procedure Types:

Therapeutic Plasma Exchange (TPE)
Red Blood Cell Exchange (RBCX)
Cellular Depletions

By Technology:

Centrifugation
Membrane filtration

By Application:

Hematology
Neurology
Nephrology
Rheumatology
Oncology
Others

By End User:

Hospitals
Blood banks
Specialty clinics

By Region:

North America
Latin America
Asia Pacific
MEA
Europe

Frequently Asked Questions

What is the Therapeutic Apheresis Market CAGR for 2033?

The Therapeutic Apheresis Market CAGR for 2033 is 5.2%.

How Big Will the Therapeutic Apheresis Market be by 2033?

The market is estimated to reach US$ 5,264.4 million by 2033.

Who are the Key Therapeutic Apheresis Market Players?

Key market players in the Therapeutic Apheresis Market are Terumo BCT, Inc., Fresenius SE & Co. KGaA, and Haemonetics Corporation.

What is the Current Market Valuation of the Therapeutic Apheresis Market?

The market is estimated to secure a valuation of US$ 2,717.9 million in 2023.

What are the Current Trends in the Therapeutic Apheresis Market?

The market for apheresis is being driven by an increase in chronic disorders. Personal apheresis is expanding with new technology and home use. Patient security is a top priority.

Table of Content

1. Executive Summary
    1.1. Global Market Outlook
    1.2. Demand-side Trends
    1.3. Supply-side Trends
    1.4. Technology Roadmap Analysis
    1.5. Analysis and Recommendations
2. Market Overview
    2.1. Market Coverage / Taxonomy
    2.2. Market Definition / Scope / Limitations
3. Market Background
    3.1. Market Dynamics
        3.1.1. Drivers
        3.1.2. Restraints
        3.1.3. Opportunity
        3.1.4. Trends
    3.2. Scenario Forecast
        3.2.1. Demand in Optimistic Scenario
        3.2.2. Demand in Likely Scenario
        3.2.3. Demand in Conservative Scenario
    3.3. Opportunity Map Analysis
    3.4. Investment Feasibility Matrix
    3.5. PESTLE and Porter’s Analysis
    3.6. Regulatory Landscape
        3.6.1. By Key Regions
        3.6.2. By Key Countries
    3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
    4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
        4.2.1. Y-o-Y Growth Trend Analysis
        4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Procedure Types
    5.1. Introduction / Key Findings
    5.2. Historical Market Size Value (US$ Million) Analysis By Procedure Types, 2018 to 2022
    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Procedure Types, 2023 to 2033
        5.3.1. Therapeutic Plasma Exchange (TPE)
        5.3.2. Red Blood Cell Exchange (RBCX)
        5.3.3. Cellular Depletions
    5.4. Y-o-Y Growth Trend Analysis By Procedure Types, 2018 to 2022
    5.5. Absolute $ Opportunity Analysis By Procedure Types, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Technology
    6.1. Introduction / Key Findings
    6.2. Historical Market Size Value (US$ Million) Analysis By Technology, 2018 to 2022
    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Technology, 2023 to 2033
        6.3.1. Centrifugation
        6.3.2. Membrane filtration
    6.4. Y-o-Y Growth Trend Analysis By Technology, 2018 to 2022
    6.5. Absolute $ Opportunity Analysis By Technology, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application
    7.1. Introduction / Key Findings
    7.2. Historical Market Size Value (US$ Million) Analysis By Application, 2018 to 2022
    7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2023 to 2033
        7.3.1. Hematology
        7.3.2. Neurology
        7.3.3. Nephrology
        7.3.4. Rheumatology
        7.3.5. Oncology
        7.3.6. Others
    7.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022
    7.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
    8.1. Introduction / Key Findings
    8.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018 to 2022
    8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023 to 2033
        8.3.1. Hospitals
        8.3.2. Blood Banks
        8.3.3. Specialty Clinics
    8.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022
    8.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033
9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
    9.1. Introduction
    9.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
    9.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
        9.3.1. North America
        9.3.2. Latin America
        9.3.3. Western Europe
        9.3.4. Eastern Europe
        9.3.5. South Asia and Pacific
        9.3.6. East Asia
        9.3.7. Middle East and Africa
    9.4. Market Attractiveness Analysis By Region
10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
        10.2.1. By Country
            10.2.1.1. USA
            10.2.1.2. Canada
        10.2.2. By Procedure Types
        10.2.3. By Technology
        10.2.4. By Application
        10.2.5. By End User
    10.3. Market Attractiveness Analysis
        10.3.1. By Country
        10.3.2. By Procedure Types
        10.3.3. By Technology
        10.3.4. By Application
        10.3.5. By End User
    10.4. Key Takeaways
11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
        11.2.1. By Country
            11.2.1.1. Brazil
            11.2.1.2. Mexico
            11.2.1.3. Rest of Latin America
        11.2.2. By Procedure Types
        11.2.3. By Technology
        11.2.4. By Application
        11.2.5. By End User
    11.3. Market Attractiveness Analysis
        11.3.1. By Country
        11.3.2. By Procedure Types
        11.3.3. By Technology
        11.3.4. By Application
        11.3.5. By End User
    11.4. Key Takeaways
12. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
        12.2.1. By Country
            12.2.1.1. Germany
            12.2.1.2. UK
            12.2.1.3. France
            12.2.1.4. Spain
            12.2.1.5. Italy
            12.2.1.6. Rest of Western Europe
        12.2.2. By Procedure Types
        12.2.3. By Technology
        12.2.4. By Application
        12.2.5. By End User
    12.3. Market Attractiveness Analysis
        12.3.1. By Country
        12.3.2. By Procedure Types
        12.3.3. By Technology
        12.3.4. By Application
        12.3.5. By End User
    12.4. Key Takeaways
13. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
        13.2.1. By Country
            13.2.1.1. Poland
            13.2.1.2. Russia
            13.2.1.3. Czech Republic
            13.2.1.4. Romania
            13.2.1.5. Rest of Eastern Europe
        13.2.2. By Procedure Types
        13.2.3. By Technology
        13.2.4. By Application
        13.2.5. By End User
    13.3. Market Attractiveness Analysis
        13.3.1. By Country
        13.3.2. By Procedure Types
        13.3.3. By Technology
        13.3.4. By Application
        13.3.5. By End User
    13.4. Key Takeaways
14. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
        14.2.1. By Country
            14.2.1.1. India
            14.2.1.2. Bangladesh
            14.2.1.3. Australia
            14.2.1.4. New Zealand
            14.2.1.5. Rest of South Asia and Pacific
        14.2.2. By Procedure Types
        14.2.3. By Technology
        14.2.4. By Application
        14.2.5. By End User
    14.3. Market Attractiveness Analysis
        14.3.1. By Country
        14.3.2. By Procedure Types
        14.3.3. By Technology
        14.3.4. By Application
        14.3.5. By End User
    14.4. Key Takeaways
15. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
    15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
        15.2.1. By Country
            15.2.1.1. China
            15.2.1.2. Japan
            15.2.1.3. South Korea
        15.2.2. By Procedure Types
        15.2.3. By Technology
        15.2.4. By Application
        15.2.5. By End User
    15.3. Market Attractiveness Analysis
        15.3.1. By Country
        15.3.2. By Procedure Types
        15.3.3. By Technology
        15.3.4. By Application
        15.3.5. By End User
    15.4. Key Takeaways
16. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
    16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
        16.2.1. By Country
            16.2.1.1. GCC Countries
            16.2.1.2. South Africa
            16.2.1.3. Israel
            16.2.1.4. Rest of MEA
        16.2.2. By Procedure Types
        16.2.3. By Technology
        16.2.4. By Application
        16.2.5. By End User
    16.3. Market Attractiveness Analysis
        16.3.1. By Country
        16.3.2. By Procedure Types
        16.3.3. By Technology
        16.3.4. By Application
        16.3.5. By End User
    16.4. Key Takeaways
17. Key Countries Market Analysis
    17.1. USA
        17.1.1. Pricing Analysis
        17.1.2. Market Share Analysis, 2022
            17.1.2.1. By Procedure Types
            17.1.2.2. By Technology
            17.1.2.3. By Application
            17.1.2.4. By End User
    17.2. Canada
        17.2.1. Pricing Analysis
        17.2.2. Market Share Analysis, 2022
            17.2.2.1. By Procedure Types
            17.2.2.2. By Technology
            17.2.2.3. By Application
            17.2.2.4. By End User
    17.3. Brazil
        17.3.1. Pricing Analysis
        17.3.2. Market Share Analysis, 2022
            17.3.2.1. By Procedure Types
            17.3.2.2. By Technology
            17.3.2.3. By Application
            17.3.2.4. By End User
    17.4. Mexico
        17.4.1. Pricing Analysis
        17.4.2. Market Share Analysis, 2022
            17.4.2.1. By Procedure Types
            17.4.2.2. By Technology
            17.4.2.3. By Application
            17.4.2.4. By End User
    17.5. Germany
        17.5.1. Pricing Analysis
        17.5.2. Market Share Analysis, 2022
            17.5.2.1. By Procedure Types
            17.5.2.2. By Technology
            17.5.2.3. By Application
            17.5.2.4. By End User
    17.6. UK
        17.6.1. Pricing Analysis
        17.6.2. Market Share Analysis, 2022
            17.6.2.1. By Procedure Types
            17.6.2.2. By Technology
            17.6.2.3. By Application
            17.6.2.4. By End User
    17.7. France
        17.7.1. Pricing Analysis
        17.7.2. Market Share Analysis, 2022
            17.7.2.1. By Procedure Types
            17.7.2.2. By Technology
            17.7.2.3. By Application
            17.7.2.4. By End User
    17.8. Spain
        17.8.1. Pricing Analysis
        17.8.2. Market Share Analysis, 2022
            17.8.2.1. By Procedure Types
            17.8.2.2. By Technology
            17.8.2.3. By Application
            17.8.2.4. By End User
    17.9. Italy
        17.9.1. Pricing Analysis
        17.9.2. Market Share Analysis, 2022
            17.9.2.1. By Procedure Types
            17.9.2.2. By Technology
            17.9.2.3. By Application
            17.9.2.4. By End User
    17.10. Poland
        17.10.1. Pricing Analysis
        17.10.2. Market Share Analysis, 2022
            17.10.2.1. By Procedure Types
            17.10.2.2. By Technology
            17.10.2.3. By Application
            17.10.2.4. By End User
    17.11. Russia
        17.11.1. Pricing Analysis
        17.11.2. Market Share Analysis, 2022
            17.11.2.1. By Procedure Types
            17.11.2.2. By Technology
            17.11.2.3. By Application
            17.11.2.4. By End User
    17.12. Czech Republic
        17.12.1. Pricing Analysis
        17.12.2. Market Share Analysis, 2022
            17.12.2.1. By Procedure Types
            17.12.2.2. By Technology
            17.12.2.3. By Application
            17.12.2.4. By End User
    17.13. Romania
        17.13.1. Pricing Analysis
        17.13.2. Market Share Analysis, 2022
            17.13.2.1. By Procedure Types
            17.13.2.2. By Technology
            17.13.2.3. By Application
            17.13.2.4. By End User
    17.14. India
        17.14.1. Pricing Analysis
        17.14.2. Market Share Analysis, 2022
            17.14.2.1. By Procedure Types
            17.14.2.2. By Technology
            17.14.2.3. By Application
            17.14.2.4. By End User
    17.15. Bangladesh
        17.15.1. Pricing Analysis
        17.15.2. Market Share Analysis, 2022
            17.15.2.1. By Procedure Types
            17.15.2.2. By Technology
            17.15.2.3. By Application
            17.15.2.4. By End User
    17.16. Australia
        17.16.1. Pricing Analysis
        17.16.2. Market Share Analysis, 2022
            17.16.2.1. By Procedure Types
            17.16.2.2. By Technology
            17.16.2.3. By Application
            17.16.2.4. By End User
    17.17. New Zealand
        17.17.1. Pricing Analysis
        17.17.2. Market Share Analysis, 2022
            17.17.2.1. By Procedure Types
            17.17.2.2. By Technology
            17.17.2.3. By Application
            17.17.2.4. By End User
    17.18. China
        17.18.1. Pricing Analysis
        17.18.2. Market Share Analysis, 2022
            17.18.2.1. By Procedure Types
            17.18.2.2. By Technology
            17.18.2.3. By Application
            17.18.2.4. By End User
    17.19. Japan
        17.19.1. Pricing Analysis
        17.19.2. Market Share Analysis, 2022
            17.19.2.1. By Procedure Types
            17.19.2.2. By Technology
            17.19.2.3. By Application
            17.19.2.4. By End User
    17.20. South Korea
        17.20.1. Pricing Analysis
        17.20.2. Market Share Analysis, 2022
            17.20.2.1. By Procedure Types
            17.20.2.2. By Technology
            17.20.2.3. By Application
            17.20.2.4. By End User
    17.21. GCC Countries
        17.21.1. Pricing Analysis
        17.21.2. Market Share Analysis, 2022
            17.21.2.1. By Procedure Types
            17.21.2.2. By Technology
            17.21.2.3. By Application
            17.21.2.4. By End User
    17.22. South Africa
        17.22.1. Pricing Analysis
        17.22.2. Market Share Analysis, 2022
            17.22.2.1. By Procedure Types
            17.22.2.2. By Technology
            17.22.2.3. By Application
            17.22.2.4. By End User
    17.23. Israel
        17.23.1. Pricing Analysis
        17.23.2. Market Share Analysis, 2022
            17.23.2.1. By Procedure Types
            17.23.2.2. By Technology
            17.23.2.3. By Application
            17.23.2.4. By End User
18. Market Structure Analysis
    18.1. Competition Dashboard
    18.2. Competition Benchmarking
    18.3. Market Share Analysis of Top Players
        18.3.1. By Regional
        18.3.2. By Procedure Types
        18.3.3. By Technology
        18.3.4. By Application
        18.3.5. By End User
19. Competition Analysis
    19.1. Competition Deep Dive
        19.1.1. Asahi Kasei Medical Co.
            19.1.1.1. Overview
            19.1.1.2. Product Portfolio
            19.1.1.3. Profitability by Market Segments
            19.1.1.4. Sales Footprint
            19.1.1.5. Strategy Overview
                19.1.1.5.1. Marketing Strategy
        19.1.2. Haemonetics Corporation
            19.1.2.1. Overview
            19.1.2.2. Product Portfolio
            19.1.2.3. Profitability by Market Segments
            19.1.2.4. Sales Footprint
            19.1.2.5. Strategy Overview
                19.1.2.5.1. Marketing Strategy
        19.1.3. Miltenyi Biotec
            19.1.3.1. Overview
            19.1.3.2. Product Portfolio
            19.1.3.3. Profitability by Market Segments
            19.1.3.4. Sales Footprint
            19.1.3.5. Strategy Overview
                19.1.3.5.1. Marketing Strategy
        19.1.4. Cerus Corporation
            19.1.4.1. Overview
            19.1.4.2. Product Portfolio
            19.1.4.3. Profitability by Market Segments
            19.1.4.4. Sales Footprint
            19.1.4.5. Strategy Overview
                19.1.4.5.1. Marketing Strategy
        19.1.5. Terumo BCT Inc.
            19.1.5.1. Overview
            19.1.5.2. Product Portfolio
            19.1.5.3. Profitability by Market Segments
            19.1.5.4. Sales Footprint
            19.1.5.5. Strategy Overview
                19.1.5.5.1. Marketing Strategy
        19.1.6. Fresenius Kabi USA
            19.1.6.1. Overview
            19.1.6.2. Product Portfolio
            19.1.6.3. Profitability by Market Segments
            19.1.6.4. Sales Footprint
            19.1.6.5. Strategy Overview
                19.1.6.5.1. Marketing Strategy
        19.1.7. Terumo Bct
            19.1.7.1. Overview
            19.1.7.2. Product Portfolio
            19.1.7.3. Profitability by Market Segments
            19.1.7.4. Sales Footprint
            19.1.7.5. Strategy Overview
                19.1.7.5.1. Marketing Strategy
        19.1.8. B. Braun Melsungen AG
            19.1.8.1. Overview
            19.1.8.2. Product Portfolio
            19.1.8.3. Profitability by Market Segments
            19.1.8.4. Sales Footprint
            19.1.8.5. Strategy Overview
                19.1.8.5.1. Marketing Strategy
        19.1.9. Nikkiso Co. Ltd.
            19.1.9.1. Overview
            19.1.9.2. Product Portfolio
            19.1.9.3. Profitability by Market Segments
            19.1.9.4. Sales Footprint
            19.1.9.5. Strategy Overview
                19.1.9.5.1. Marketing Strategy
        19.1.10. Medica S.p.A.
            19.1.10.1. Overview
            19.1.10.2. Product Portfolio
            19.1.10.3. Profitability by Market Segments
            19.1.10.4. Sales Footprint
            19.1.10.5. Strategy Overview
                19.1.10.5.1. Marketing Strategy
        19.1.11. Baxter Healthcare Corporation
            19.1.11.1. Overview
            19.1.11.2. Product Portfolio
            19.1.11.3. Profitability by Market Segments
            19.1.11.4. Sales Footprint
            19.1.11.5. Strategy Overview
                19.1.11.5.1. Marketing Strategy
        19.1.12. Kawasumi Laboratories Inc.
            19.1.12.1. Overview
            19.1.12.2. Product Portfolio
            19.1.12.3. Profitability by Market Segments
            19.1.12.4. Sales Footprint
            19.1.12.5. Strategy Overview
                19.1.12.5.1. Marketing Strategy
        19.1.13. Therakos Incorporation
            19.1.13.1. Overview
            19.1.13.2. Product Portfolio
            19.1.13.3. Profitability by Market Segments
            19.1.13.4. Sales Footprint
            19.1.13.5. Strategy Overview
                19.1.13.5.1. Marketing Strategy
20. Assumptions & Acronyms Used
21. Research Methodology

Therapeutic Apheresis Market

Analysis of the Therapeutic Apheresis Market by Therapeutic Plasma Exchange (TPE), Red Blood Cell Exchange (RBCX), and Cellular Depletions